Cronus Pharma Launches Clindamycin Hydrochloride Oral Liquid

Expands Portfolio to Five Products

EAST BRUNSWICK, N.J.–(BUSINESS WIRE)–Cronus Pharma LLC, an emerging animal health company focused on the
development and marketing of prescription pharmaceuticals to improve the
lives and health of companion animals, announced the commercial launch
of Clindamycin Hydrochloride Oral Liquid (25mg/20mL) in a 20mL bottle, a
generic version of Antirobe Aquadrops®. Clindamycin hydrochloride oral
liquid is FDA approved for use in cats and dogs, indicated for specific
treatments of skin infections, deep wounds, abscesses, osteomyelitis and
dental infections caused by susceptible strains of specific

The product is currently commercially available through the Cronus
network of national and regional veterinary wholesalers and distributors.

Cronus’ clindamycin hydrochloride oral liquid is the first product
launched from the portfolio of products acquired from a leading global
pharmaceutical company in 2014. Cronus plans to introduce several
additional key products from this acquisition as well as launch
internally developed products over the next few quarters. Edward
Neugeboren, Chief Strategy Officer of Cronus Pharma stated, “This
product launch is a key corporate milestone for Cronus as it the first
product launched from our large portfolio acquired in 2014. Importantly,
we have expanded our product portfolio to five products, with plans to
continue introducing numerous additional products over the coming
quarters and beyond. We are proud of our efforts in building a reliable
and scalable supply chain to support the needs of our clients.
Furthermore, our strategy of investing in internally developing products
coupled with acquiring products is achieving our goal of building a
diversified portfolio of cost effective companion animal
pharmaceuticals. Our growing product pipeline consists of over 20
products representing an addressable market approximating $350 million.”

Cronus firmly believes that pets, their owners and their veterinarians
benefit from a marketplace with reliable generic alternatives to more
costly branded pharmaceuticals. Cronus will continue to launch
affordable veterinary pharmaceuticals into the companion animal market
as development, licensing and acquisition projects mature.

Antirobe Aquadrops® is a registered trademark of Zoetis.

About Cronus Pharma

Cronus Pharma is an emerging privately held veterinary generic
pharmaceutical company located in East Brunswick, New Jersey, dedicated
to providing innovative and cost effective products to the animal health
market. Our team of seasoned industry professionals have been intimately
involved in the establishment, and growth of several pharmaceutical
manufacturing and distribution firms in both the human and animal health
pharmaceutical industries. Through our in house R&D and licensing,
Cronus brings several differentiated generic products serving the
companion animal markets. We have a growing portfolio of over 20
products having recently acquired a large product portfolio from one of
the leading global pharmaceutical companies. We are dedicated to
investing in research & development and have an extensive team of
scientists developing innovative products. Several products are under
development as well as pending FDA approval. Fully licensed in all 50
states to distribute pharmaceutical products, our products are
accessible to all veterinarians and pet owners nationwide at major
wholesalers and regional distributors. Our passionate team is committed
to growing our business and being among the leading veterinary generic
pharmaceutical companies in the country.

Additional information is available on the company’s website at


Cronus Pharma
Business Development
Mr. Edward
Chief Strategy Officer
Phone: 732-243-8471
Tower Center Boulevard, Suite 1101C, East Brunswick, NJ 08816

Phone: 844-2-CRONUS (844-227-6687)
Hours: 9:00 am – 6:00 pm EST, Monday – Friday